商標登録insideNews: Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn | Business Standard News

Eris Lifesciences on Tuesday announced acquisition of the trademark Zomelis, for Vildagliptin-based formulations, and its associated trademarks from Novartis AG, Switzerland, for a consideration of $13 million (roughly Rs 93 crore).

情報源: Eris Lifesciences acquires trademark Zomelis from Novartis AG for $13 mn | Business Standard News

コメントを残す

メールアドレスが公開されることはありません。

CAPTCHA